24-24 April 2023
Qmed+
REGISTER NOW
keyboard_arrow_left See all news

Recent News

27 Sep, 2022 /
Nordson Medical
Nordson MEDICAL Opens Tecate Mexico Medical Device Manufacturing Facility
Nordson MEDICAL announces the official opening of its Tecate, Mexico, Medical Device Man...
14 Sep, 2022 /
Qosina
Qosina Expands Class VI Tubing Portfolio for Single-Use Medical Device and Bioprocess Applications
Qosina expands its Class VI tubing portfolio with several new brands
26 Aug, 2022 /
Smalley
Smalley Wins GM Supplier Quality Excellence Award for 10th Consecutive Year
Smalley receives the General Motors Supplier Quality Excellence Award for the 10th conse...
26 Jul, 2022 /
Qosina
Qosina Adds the AseptiQuik STC Series to Its Line of Steam-Thru Connectors
Qosina introduces the AseptiQuik® STC connectors to its line of Steam-Thru® connectors
08 Jul, 2022 /
Smalley
Smalley Europe Celebrates 20 Years of Local Service
Smalley celebrates 20 years in the European market
Phillips-Medisize, a Molex company
/ 09 Apr, 2019
keyboard_arrow_left See all news

Phillips-Medisize Announces Expansion of Significant Medical Customer for Molex Little Rock Facility

HUDSON, WI – January 18, 2018 – phillipsmedisize – Phillips-Medisize, a Molex company, announces the expansion of a significant medical customer for the Molex Little Rock facility. The long-time customer is a leader in consumable diagnostics cancer testing, with its take-home diagnostic kit for cancer detection.

This is an exciting expansion for both the customer and Phillips-Medisize as it will double production, as the device is currently being produced in the Phillips-Medisize New Richmond facility. A second set of molding and dedicated automation machines to package and assemble the device will now be needed for the expanded production footprint in Little Rock.

Phillips-Medisize will mold, assemble with high speed automation, package and label the patient-ready device in the newly registered FDA facility, with production expected to begin in Q2 2018. This product will also include reagent handling and require unique device identification (UDI). Phillips-Medisize will utilize the number of the highly trained and qualified staff that already exists in the Little Rock operation.

The Little Rock facility establishes a new manufacturing site for Phillips-Medisize's medical business with capabilities for filling, drug handling, electronics and connected devices. This investment aims to combine the innovative solutions and knowledge of Molex's existing high volume automated electronics production operations with Phillips-Medisize's proven platform of drug delivery and medical device expertise.

Matt Jennings, CEO and President of Phillips-Medisize comments, “We are looking forward to expanding production with our customer and partnering with the Molex Little Rock team on this program. The team provides decades of experience in molding and assembly operations, cutting edge automation and quality control technology, as well as instant access to a team of highly talented and knowledgeable employees. We believe that Little Rock is the right location for our customer and will support both of our ambitious growth plans.”

Processing. Please wait.
Loading...